Skip to main content
Log in

Kisspeptin expression features in the arcuate and anteroventral periventricular nuclei of hypothalamus of letrozole-induced polycystic ovarian syndrome in rats

  • General Gynecology
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Purpose

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder of the reproductive system characterized by polycystic ovaries and androgen excess. Letrozole is a nonsteroidal aromatase inhibitor that is used in experimental research to induce PCOS. Kisspeptin is an essential protein in regulation of cyclicity. Kisspeptin receptor is expressed in the hypothalamus and pituitary glands, and kisspeptin containing neurons are affected from sex steroid hormones. We aimed to investigate the number of kisspeptin-positive cells in the arcuate (Arc) and anteroventral periventricular nuclei (AVPV) of hypothalamus in the letrozole-induced PCOS.

Methods

40 female Wistar rats were divided into the proestrus control, diestrus control, proestrus vehicle, diestrus vehicle and letrozole. Animals were sacrificed after 3 weeks, and sera, ovary and brain samples were harvested for further evaluations.

Results

Letrozole group had high weight gain, high numbers of ovarian follicular cysts, high levels of luteinizing hormone and testosterone and increase number of kisspeptin-positive cells in the Arc nucleus, as compared with the control groups (P ≤ 0.05 vs. proestrus control and proestrus vehicle). Letrozole group showed a decrease in the number of kisspeptin-positive cells in the AVPV nucleus (P ≤ 0.05 vs. proestrus control and proestrus vehicle).

Conclusion

Our findings show that the number of kisspeptin-positive cells may be affected from letrozole, and that the changes in the number of these cells may be in favor of the appearance of PCOS features in this group.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Suvarna Y et al (2016) Comparison of efficacy of metformin and oral contraceptive combination of ethinyl estradiol and drospirenone in polycystic ovary syndrome. J Turk Ger Gynecol Assoc 17(1):6–9

    Article  PubMed  PubMed Central  Google Scholar 

  2. El Hayek S et al. (2016) Poly cystic ovarian syndrome: an updated overview. Front Physiol 7:124

    Article  PubMed  PubMed Central  Google Scholar 

  3. Baskind NE, Balen AH (2016) Hypothalamic–pituitary, ovarian and adrenal contributions to polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 37:80–97

    Article  PubMed  Google Scholar 

  4. Walters KA (2016) Androgens in polycystic ovary syndrome: lessons from experimental models. Curr Opin Endocrinol Diabetes Obes 23(3):257–263

    Article  CAS  PubMed  Google Scholar 

  5. Nekoonam S et al (2017) Expression of AKT1 along with AKT2 in granulosa-lutein cells of hyperandrogenic PCOS patients. Arch Gynecol Obstet 4(295):1041–1050

    Article  Google Scholar 

  6. Kondo M et al (2016) Increase of kisspeptin-positive cells in the hypothalamus of a rat model of polycystic ovary syndrome. Metab Brain Dis 31(3):673–681

    Article  CAS  PubMed  Google Scholar 

  7. Kelley ST et al (2016) The gut microbiome is altered in a letrozole-induced mouse model of polycystic ovary syndrome. PLoS One 11(1):e0146509

    Article  PubMed  PubMed Central  Google Scholar 

  8. Tsui K-H, Huang B-S, Wang P-H (2016) Kisspeptin system in female reproduction: a next-generation target in the manipulation of sex hormones. J Chin Med Assoc 79(10):519–520

    Article  PubMed  Google Scholar 

  9. Baravalle C et al (2006) Microscopic characterization of follicular structures in letrozole-induced polycystic ovarian syndrome in the rat. Arch Med Res 37(7):830–839

    Article  CAS  PubMed  Google Scholar 

  10. Kafali H et al (2004) Letrozole-induced polycystic ovaries in the rat: a new model for cystic ovarian disease. Arch Med Res 35(2):103–108

    Article  CAS  PubMed  Google Scholar 

  11. Li D et al (2016) Differential expression of microRNAs in the ovaries from letrozole-induced rat model of polycystic ovary syndrome. DNA Cell Biol 35(4):177–183

    Article  CAS  PubMed  Google Scholar 

  12. Manneras L et al (2007) A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome. Endocrinology 148(8):3781–3791

    Article  PubMed  Google Scholar 

  13. Osuka S et al (2016) Kisspeptin in the hypothalamus of 2 rat models of polycystic ovary syndrome. Endocrinology 158(2):367–377

    Google Scholar 

  14. Gresham R et al (2016) Kisspeptin in the medial amygdala and sexual behavior in male rats. Neurosci Lett 627:13–17

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Yap C et al (2016) Diurnal regulation of hypothalamic kisspeptin is disrupted during mouse pregnancy. J Endocrinol 229(3):307–318

    Article  CAS  PubMed  Google Scholar 

  16. Emekci Ozay O et al (2016) Role of kisspeptin in polycystic ovary syndrome (PCOS). Gynecol Endocrinol 32(9):718–722

    Article  CAS  PubMed  Google Scholar 

  17. Smith JT et al (2011) Kisspeptin is essential for the full preovulatory LH surge and stimulates GnRH release from the isolated ovine median eminence. Endocrinology 152(3):1001–1012

    Article  CAS  PubMed  Google Scholar 

  18. Mohr MA et al (2016) Neurons and glial cells are added to the female rat anteroventral periventricular nucleus during puberty. Endocrinology 157(6):2393–2402

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Uenoyama Y et al (2016) Molecular and epigenetic mechanism regulating hypothalamic kiss1 gene expression in mammals. Neuroendocrinology 103(6):640–649

    Article  CAS  PubMed  Google Scholar 

  20. Brown RE et al (2012) Hypothalamic kiss1 mRNA and kisspeptin immunoreactivity are reduced in a rat model of polycystic ovary syndrome (PCOS). Brain Res 1467:1–9. doi:10.1016/j.brainres.2012.05.049

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This study was supported in part by Shiraz University of Medical Sciences.

Author information

Authors and Affiliations

Authors

Contributions

EA: conceptualization; KM: manuscript writing, data curation and revision of the final manuscript; MRN: methodology; HT: corresponding, methodology and data analysis; SK: conceptualization; HM: format analysis of data; MA: conceptualization; TR: conceptualization; SS: data curation.

Corresponding author

Correspondence to Heidar Toolee.

Ethics declarations

Conflict of interest

The authors of the current paper declare no conflict of interest with regard to all time periods of working—neither financial support nor personal relationship. Elham Aliabadi, Mohammad Reza Namavar, Keywan Mortezaee, Heidar Toolee, Sara Keshtgar, Hossein Mirkhani, Mohammad Akbari, Tayebeh Rastegar and Somayeh Solhjoo declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Aliabadi, E., Namavar, M.R., Mortezaee, K. et al. Kisspeptin expression features in the arcuate and anteroventral periventricular nuclei of hypothalamus of letrozole-induced polycystic ovarian syndrome in rats. Arch Gynecol Obstet 296, 957–963 (2017). https://doi.org/10.1007/s00404-017-4509-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-017-4509-3

Keywords

Navigation